This book highlights the special issues arising in obtaining, commercialising, enforcing or attacking intellectual property rights (including protection of regulatory data) in the pharmaceutical, biotechnology and chemical industries across the world's key jurisdictions. It is unique in presenting topic matter horizontally by subject to facilitate comparison between country practices.
The jurisdictions covered are the United States, Europe (UK, Germany, Netherlands, France and Italy), Japan, Canada, Australia, India and China.

Pharmaceuticals Biotechnology and the Law is the definitive guide to the law in Europe relating to pharmaceuticals, biotechnology and their related areas such as medical devices.
Written by one of the country's leading patent and regulatory lawyers, this is the only text which comprehensively covers the wide variety of legal and regulatory issues which surround these industry sectors.
The book examines the background to, and the impact of, the law affecting this area. The text is primarily written from the perspective of European Community law, although in those relatively few areas where this is not harmonised it is written from the perspective of UK rule.

Embracing relevant developments, including: the latest CAP rules on marketing standards; protected names and organic products, this new edition also considers significant changes of wider concern. Such changes include: the impact of Human Rights legislation on strict liability offences; the effect of the Government of Wales Act 2006 and the establishment of the Department for Environment, Food and Rural Affairs.

This is the eagerly awaited fourth edition of Philip Grubb's acclaimed book on patent law and practice. It guides the reader through the legal and procedural complexities of the British, European, Japanese and US patent systems, and explains in detail the role of patent practitioners (both in-house and in private practice) in maximising the commercial potential of their client's or company's innovative products.

This book is a practical guide to the major IP issues pharmaceutical companies encounter when bringing new products to the market as well as issues they need to deal with post-commercialization.
Giving you an overview of the regulatory environment from a national and international perspective this title provides you with an understanding of this area of law and all it involves. It explains how patents and other IP protection can be used for new and innovative products enabling you to see what can be done to protect your new products.